| PMID |
16242643 ( ![]() ![]() ![]() ) |
|---|---|
| Title | Minocycline fails to protect cerebellar granular cell cultures against malonate-induced cell death. |
| Abstract | Experimental and clinical studies support the view that the semisynthetic tetracycline minocycline exhibits neuroprotective roles in several models of neurodegenerative diseases, including ischemia, Huntington, Parkinson diseases, and amyotrophic lateral sclerosis. However, recent evidence indicates that minocycline does not always present beneficial actions. For instance, in an in vivo model of Huntington's disease, it fails to afford protection after malonate intrastriatal injection. Moreover, it reverses the neuroprotective effect of creatine in nigrostriatal dopaminergic neurons. This apparent contradiction prompted us to analyze the effect of this antibiotic on malonate-induced cell death. We show that, in rat cerebellar granular cells, the succinate dehydrogenase inhibitor malonate induces cell death in a concentration-dependent manner. By using DFCA, monochlorobimane and 10-N-nonyl-Acridin Orange to measure, respectively, H2O2-derived oxidant species and reduced forms of GSH and cardiolipin, we observed that malonate induced reactive oxygen species (ROS) production to an extent that surpasses the antioxidant defense capacity of the cells, resulting in GSH depletion and cardiolipin oxidation. The pre-treatment for 4 h with minocycline (10-100 microM) did not present cytoprotective actions. Moreover, minocycline failed to block ROS production and to abrogate malonate-induced oxidation of GSH and cardiolipin. Additional experiments revealed that minocycline was also unsuccessful to prevent the mitochondrial swelling induced by malonate. Furthermore, malonate did not induce the expression of the iNOS, caspase-3, -8, and -9 genes which have been shown to be up-regulated in several models where minocycline resulted cytoprotective. In addition, malonate-induced down-regulation of the antiapoptotic gene Bcl-2 was not prevented by minocycline, controversially the mechanism previously proposed to explain minocycline protective action. These results suggest that the minocycline protection observed in several neurodegenerative disease models is selective, since it is absent from cultured cerebellar granular cells challenged with malonate. Castilla-La Mancha, Avda, Almansa, s/n, 02006 Albacete, Spain. |
NOTE: Color highlight is limited to the abstract and SciMiner text-mining mode. If you see much more identified targets below from "Targets by SciMiner Summary" and "Targets by SciMiner Full list", they may have been identified from the full text.
Targets by SciMiner Summary
| HUGO ID | Symbol | Target Name | #Occur | ActualStr |
|---|---|---|---|---|
| 990 | BCL2 | B-cell CLL/lymphoma 2 | 28 | Bcl-2 | bcl 2 | |
| 7873 | NOS2A | nitric oxide synthase 2A (inducible, hepatocytes) | 13 | iNOS | nitric oxide synthase | |
| 1504 | CASP3 | caspase 3, apoptosis-related cysteine peptidase | 10 | caspase 3 | |
| 19986 | CYCS | cytochrome c, somatic | 3 | cytochrome c | |
| 21528 | DIABLO | diablo homolog (Drosophila) | 2 | DIABLO | SMAC | |
| 5992 | IL1B | interleukin 1, beta | 1 | interleukin 1 beta | |
| 4141 | GAPDH | glyceraldehyde-3-phosphate dehydrogenase | 1 | GAPDH | |
| 399 | ALB | albumin | 1 | serum albumin | |
| 11920 | FAS | Fas (TNF receptor superfamily, member 6) | 1 | Fas | |
| 8768 | AIFM1 | apoptosis-inducing factor, mitochondrion-associated, 1 | 1 | apoptosis inducing factor | |
Targets by SciMiner Full list
| HUGO ID | Symbol | Name | ActualStr | Score | FlankingText |
|---|---|---|---|---|---|
| 7873 | NOS2A | nitric oxide synthase 2A (inducible, hepatocytes) | iNOS | 2.5 | Furthermore malonate did not induce the expression of the iNOS caspase-3 -8 and -9 genes which have been shown to |
| 990 | BCL2 | B-cell CLL/lymphoma 2 | Bcl-2 | 6.2 | In addition malonate-induced down-regulation of the antiapoptotic gene Bcl-2 was not prevented by minocycline controversially the mechanism previously proposed |
| 7873 | NOS2A | nitric oxide synthase 2A (inducible, hepatocytes) | iNOS | 2.5 | expression of interleukin 1 beta inducible nitric oxide synthase (iNOS), iNOS caspase-3 and -1 ( Chen et al. 2000 |
| 21528 | DIABLO | diablo homolog (Drosophila) | SMAC | 1.8 | turn inhibits the release of the proapoptotic factors cytochrome c SMAC (DIABLO) DIABLO and apoptosis-inducing factor from the mitochondria ( Wang |
| 21528 | DIABLO | diablo homolog (Drosophila) | DIABLO | 1.8 | the release of the proapoptotic factors cytochrome c SMAC (DIABLO) DIABLO and apoptosis-inducing factor from the mitochondria ( Wang et al. |
| 7873 | NOS2A | nitric oxide synthase 2A (inducible, hepatocytes) | iNOS | 2.5 | no modifications in the expression of the mRNA's encoding for iNOS caspase-3 -8 and -9 after malonate additions were found we |
| 4141 | GAPDH | glyceraldehyde-3-phosphate dehydrogenase | GAPDH | 0.3 | (Cycle Cycle threshold method ( Livak and Schmittgen 2001 using GAPDH as internal control once demonstrated that the efficiency for the |
| 7873 | NOS2A | nitric oxide synthase 2A (inducible, hepatocytes) | iNOS | 2.5 | iNOS caspase-3 -8 and -9 mRNA expression levels are not modulated |
| 7873 | NOS2A | nitric oxide synthase 2A (inducible, hepatocytes) | iNOS | 2.5 | Among them the down-regulation of caspases and iNOS and the up-regulation of Bcl-2 have been documented recently ( |
| 990 | BCL2 | B-cell CLL/lymphoma 2 | Bcl-2 | 6.2 | the down-regulation of caspases and iNOS and the up-regulation of Bcl-2 have been documented recently ( Wang et al. 2004 |
| 7873 | NOS2A | nitric oxide synthase 2A (inducible, hepatocytes) | iNOS | 2.5 | cell death we first analyzed the pattern of expression of iNOS caspase-3 -8 and -9 and the antiapoptotic gene Bcl-2 in |
| 990 | BCL2 | B-cell CLL/lymphoma 2 | Bcl-2 | 6.2 | of iNOS caspase-3 -8 and -9 and the antiapoptotic gene Bcl-2 in malonate-treated cells |
| 7873 | NOS2A | nitric oxide synthase 2A (inducible, hepatocytes) | iNOS | 2.5 | in cell viability does not modify the expression of the iNOS caspase-3 -8 and -9 genes |
| 990 | BCL2 | B-cell CLL/lymphoma 2 | Bcl-2 | 6.2 | mM malonate caused a significant down-regulation of the antiapoptotic gene Bcl-2 ( Fig 6 B |
| 990 | BCL2 | B-cell CLL/lymphoma 2 | Bcl-2 | 6.2 | Therefore we studied whether minocycline would prevent the down-regulation of Bcl-2 gene expression induced by malonate |
| 990 | BCL2 | B-cell CLL/lymphoma 2 | Bcl-2 | 6.2 | lack of protective effect failed to block the down-regulation of Bcl-2 caused by malonate |
| 7873 | NOS2A | nitric oxide synthase 2A (inducible, hepatocytes) | iNOS | 2.5 | mRNA expression of caspase-3 -8 and -9 as well as iNOS it decreases the mRNA of the antiapoptotic protein Bcl-2 an |
| 990 | BCL2 | B-cell CLL/lymphoma 2 | Bcl-2 | 6.2 | as iNOS it decreases the mRNA of the antiapoptotic protein Bcl-2 an effect that was not abrogated by minocycline |
| 11920 | FAS | Fas (TNF receptor superfamily, member 6) | Fas | 0.3 | hydroperoxide phenylarsine oxide or non-oxidative (Ca/Pi, Ca Pi t-Bid Bid Fas mechanism ( Chu et al. 2005 Wang et al. 2003 |
| 7873 | NOS2A | nitric oxide synthase 2A (inducible, hepatocytes) | iNOS | 2.5 | be modulated by minocycline after different neurotoxic stimuli such as iNOS and several members of the caspase family ( Chen et |
| 7873 | NOS2A | nitric oxide synthase 2A (inducible, hepatocytes) | iNOS | 2.5 | no changes in the expression of the genes coding for iNOS caspase-3 -8 and -9 |
| 990 | BCL2 | B-cell CLL/lymphoma 2 | Bcl-2 | 6.2 | Conversely we did find a significant down-regulation of Bcl-2 expression after a 24-h malonate exposure |
| 990 | BCL2 | B-cell CLL/lymphoma 2 | Bcl-2 | 6.2 | It should be noted that the up-regulation of Bcl-2 gene expression has been recently proposed as a mechanism mediating |
| 990 | BCL2 | B-cell CLL/lymphoma 2 | Bcl-2 | 6.2 | present work this drug failed to reverse the down-regulation of Bcl-2 induced by malonate treatment nor induced Bcl-2 expression by itself |
| 990 | BCL2 | B-cell CLL/lymphoma 2 | Bcl-2 | 6.2 | the down-regulation of Bcl-2 induced by malonate treatment nor induced Bcl-2 expression by itself |
| 7873 | NOS2A | nitric oxide synthase 2A (inducible, hepatocytes) | iNOS | 2.5 | Fig 6._amp_#xa0 Malonate does not affect iNOS caspase-3 -8 and -9 but significantly reduces Bcl-2 mRNA expression |
| 990 | BCL2 | B-cell CLL/lymphoma 2 | Bcl-2 | 6.2 | not affect iNOS caspase-3 -8 and -9 but significantly reduces Bcl-2 mRNA expression levels mRNA expression in malonate-treated cerebellar granular cells |
| 7873 | NOS2A | nitric oxide synthase 2A (inducible, hepatocytes) | iNOS | 2.5 | (A) A Lack of effects of malonate on the iNOS caspase-3 -8 and -9 mRNA expression levels |
| 990 | BCL2 | B-cell CLL/lymphoma 2 | Bcl-2 | 6.2 | (B) B Effect of malonate on Bcl-2 mRNA expression levels |
| 990 | BCL2 | B-cell CLL/lymphoma 2 | Bcl-2 | 6.2 | Minocycline pre-treatment fails to avoid the Bcl-2 down-regulation induced by malonate |
| 1504 | CASP3 | caspase 3, apoptosis-related cysteine peptidase | caspase 3 | 1.0 | furthermore malonate did not induce the expression of the inos caspase 3 8 and 9 genes which have been shown to be up regulated in several models where minocycline resulted cytoprotective. |
| 990 | BCL2 | B-cell CLL/lymphoma 2 | bcl 2 | 1.0 | in addition malonate induced down regulation of the antiapoptotic gene bcl 2 was not prevented by minocycline controversially the mechanism previously proposed to explain minocycline protective action. |
| 5992 | IL1B | interleukin 1, beta | interleukin 1 beta | 1.0 | in this sense tetracyclines can inhibit the matrix metalloproteases activity and superoxide production and can also down regulate the levels of expression of interleukin 1 beta inducible nitric oxide synthase inos caspase 3 and 1 chen et al. 2000 . |
| 1504 | CASP3 | caspase 3, apoptosis-related cysteine peptidase | caspase 3 | 1.0 | tetracyclines can inhibit the matrix metalloproteases activity and superoxide production and can also down regulate the levels of expression of interleukin 1 beta inducible nitric oxide synthase inos caspase 3 and 1 chen et al. 2000 . |
| 7873 | NOS2A | nitric oxide synthase 2A (inducible, hepatocytes) | nitric oxide synthase | 1.0 | in this sense tetracyclines can inhibit the matrix metalloproteases activity and superoxide production and can also down regulate the levels of expression of interleukin 1 beta inducible nitric oxide synthase inos caspase 3 and 1 chen et al. 2000 . |
| 8768 | AIFM1 | apoptosis-inducing factor, mitochondrion-associated, 1 | apoptosis inducing factor | 1.0 | this blockade in turn inhibits the release of the proapoptotic factors cytochrome c smac diablo and apoptosis inducing factor from the mitochondria wang et al. 2003 and zhu et al. 2002 . |
| 19986 | CYCS | cytochrome c, somatic | cytochrome c | 1.0 | this blockade in turn inhibits the release of the proapoptotic factors cytochrome c smac diablo and apoptosis inducing factor from the mitochondria wang et al. 2003 and zhu et al. 2002 . |
| 1504 | CASP3 | caspase 3, apoptosis-related cysteine peptidase | caspase 3 | 1.0 | moreover although no modifications in the expression of the mrna's encoding for inos caspase 3 8 and 9 after malonate additions were found we observed a significant reduction of blc 2 mrna expression which was not reverted by minocycline. |
| 399 | ALB | albumin | serum albumin | 1.0 | tissues were incubated with trypsin for 20 min at 37_amp_#xb0;c and dissociated by trituration in a medium containing dnase bovine serum albumin and trypsin inhibitor. |
| 1504 | CASP3 | caspase 3, apoptosis-related cysteine peptidase | caspase 3 | 1.0 | inos caspase 3 8 and 9 mrna expression levels are not modulated by malonate |
| 990 | BCL2 | B-cell CLL/lymphoma 2 | bcl 2 | 1.0 | among them the down regulation of caspases and inos and the up regulation of bcl 2 have been documented recently wang et al. 2004 . |
| 990 | BCL2 | B-cell CLL/lymphoma 2 | bcl 2 | 1.0 | in order to check whether these pathways were involved in malonate induced granular cell death we first analyzed the pattern of expression of inos caspase 3 8 and 9 and the antiapoptotic gene bcl 2 in malonate treated cells. |
| 1504 | CASP3 | caspase 3, apoptosis-related cysteine peptidase | caspase 3 | 1.0 | in order to check whether these pathways were involved in malonate induced granular cell death we first analyzed the pattern of expression of inos caspase 3 8 and 9 and the antiapoptotic gene bcl 2 in malonate treated cells. |
| 1504 | CASP3 | caspase 3, apoptosis-related cysteine peptidase | caspase 3 | 1.0 | the results shown in fig. 6 a revealed that malonate at the concentration which causes a significant decrease in cell viability does not modify the expression of the inos caspase 3 8 and 9 genes. |
| 990 | BCL2 | B-cell CLL/lymphoma 2 | bcl 2 | 1.0 | however 50 mm malonate caused a significant down regulation of the antiapoptotic gene bcl 2 fig 6 b . |
| 990 | BCL2 | B-cell CLL/lymphoma 2 | bcl 2 | 1.0 | therefore we studied whether minocycline would prevent the down regulation of bcl 2 gene expression induced by malonate. |
| 990 | BCL2 | B-cell CLL/lymphoma 2 | bcl 2 | 1.0 | as depicted in fig. 6 b minocycline consistently with its lack of protective effect failed to block the down regulation of bcl 2 caused by malonate. |
| 990 | BCL2 | B-cell CLL/lymphoma 2 | bcl 2 | 1.0 | additionally although malonate treatment fails to induce the mrna expression of caspase 3 8 and 9 as well as inos it decreases the mrna of the antiapoptotic protein bcl 2 an effect that was not abrogated by minocycline. |
| 1504 | CASP3 | caspase 3, apoptosis-related cysteine peptidase | caspase 3 | 1.0 | additionally although malonate treatment fails to induce the mrna expression of caspase 3 8 and 9 as well as inos it decreases the mrna of the antiapoptotic protein bcl 2 an effect that was not abrogated by minocycline. |
| 19986 | CYCS | cytochrome c, somatic | cytochrome c | 1.0 | cardiolipin is a phospholipid located in the inner mitochondrial membrane whose oxidation can be the consequence of the release of cytochrome c from the mitochondria to the cytoplasm tuominen et al. 2002 a release that we have previously observed to be increased in sh sy5y cells challenged with malonate fern_amp_#xe1;ndez g_amp_#xf3;mez et a |
| 19986 | CYCS | cytochrome c, somatic | cytochrome c | 1.0 | as a consequence of permeability transition pore formation cytochrome c is released to the cytoplasm turning on the apoptotic machinery. |
| 1504 | CASP3 | caspase 3, apoptosis-related cysteine peptidase | caspase 3 | 1.0 | we found no changes in the expression of the genes coding for inos caspase 3 8 and 9. |
| 990 | BCL2 | B-cell CLL/lymphoma 2 | bcl 2 | 1.0 | conversely we did find a significant down regulation of bcl 2 expression after a 24 h malonate exposure. |
| 990 | BCL2 | B-cell CLL/lymphoma 2 | bcl 2 | 1.0 | it should be noted that the up regulation of bcl 2 gene expression has been recently proposed as a mechanism mediating minocycline induced cytoprotection wang et al. 2004 . |
| 990 | BCL2 | B-cell CLL/lymphoma 2 | bcl 2 | 1.0 | however abounding on the lack of protective effect by minocycline in the present work this drug failed to reverse the down regulation of bcl 2 induced by malonate treatment nor induced bcl 2 expression by itself. |
| 990 | BCL2 | B-cell CLL/lymphoma 2 | bcl 2 | 1.0 | fig. 6._amp_#xa0;malonate does not affect inos caspase 3 8 and 9 but significantly reduces bcl 2 mrna expression levels. mrna expression in malonate treated cerebellar granular cells was quantitatively measured by real time pcr using gadph mrna levels as control. |
| 1504 | CASP3 | caspase 3, apoptosis-related cysteine peptidase | caspase 3 | 1.0 | fig. 6._amp_#xa0;malonate does not affect inos caspase 3 8 and 9 but significantly reduces bcl 2 mrna expression levels. mrna expression in malonate treated cerebellar granular cells was quantitatively measured by real time pcr using gadph mrna levels as c |
| 1504 | CASP3 | caspase 3, apoptosis-related cysteine peptidase | caspase 3 | 1.0 | a lack of effects of malonate on the inos caspase 3 8 and 9 mrna expression levels. |
| 990 | BCL2 | B-cell CLL/lymphoma 2 | bcl 2 | 1.0 | b effect of malonate on bcl 2 mrna expression levels. |
| 990 | BCL2 | B-cell CLL/lymphoma 2 | bcl 2 | 1.0 | minocycline pre treatment fails to avoid the bcl 2 down regulation induced by malonate. |
| 990 | BCL2 | B-cell CLL/lymphoma 2 | bcl 2 | 1.0 | cardiolipins|enzyme inhibitors|malonates|neuroprotective agents|neurotoxins|proto oncogene proteins c bcl 2|reactive oxygen species|minocycline|malonic acid|glutathione|succinate dehydrogenase|caspases| |